Introduction to the Italian Pancreatic Cancer Community I-PCC
The Italian Pancreatic Cancer Community (I-PCC) is an online platform that connects Italian scientists working in basic and translational pancreatic cancer research. Established in 2021 with the support of Fondazione Nadia Valsecchi, a non-profit organization with over 10 years of experience supporting research, patients, families, and public awareness, the I-PCC aims to foster collaboration and accelerate progress in the fight against pancreatic cancer.
Our Vision
By connecting leading scientific minds, we can drive innovation and achieve more than we ever could alone.
Our Mission
To connect scientists in basic and translational research to accelerate discoveries and advance progress against pancreatic cancer.
The founding members of I-PCC are leading scientists in the field, representing 13 research laboratories across Italy and Europe:
Luigi Leanza, Università di Padova, Padua
Loretta L. del Mercato, Nanotechnology Institute – National Research Council (NANOTEC-CNR), Lecce
Paola Cappello, Department of Molecular Biotechnology and Health Sciences, University of Turin
Giuseppe R. Diaferia, Botton-Champalimaud Pancreatic Cancer Center, Champalimaud Foundation, Lisbon
Paolo E. Porporato, Molecular Biotechnology Center (MBC), University of Turin
Alessandro Carrer, Veneto Institute of Molecular Medicine (VIMM), Padua
Sara Lovisa, Humanitas University, Pieve Emanuele, and Humanitas Research Hospital, Rozzano
Vincenzo Corbo, University of Verona, Verona
Miriam Martini, Molecular Biotechnology Center (MBC), University of Turin
Federica Marchesi, Department of Medical Biotechnology and Translational Medicine, University of Milan, Rozzano
Elisa Giovannetti, Fondazione Pisana per la Scienza (FPS), Pisa & Cancer Center Amsterdam (CCA), VU University Medical Center, The Netherlands
Carmine Carbone, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome
Enza Lonardo, Institute of Genetics and Biophysics (IGB-CNR), Naples
The first I-PCC Symposium was held in Padua in April 2024, bringing together over 100 participants. Special attention was given to oral and poster presentations by young scientists. Fondazione Nadia Valsecchi, along with other patient advocacy groups, awarded travel grants to support the participation of early-career investigators.